Jason Amello

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Jason Amello
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jason Amello:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Candel Therapeutics, Inc. Chief Financial Officer Common Stock 202K $182K $0.90 Nov 28, 2023 Direct
TScan Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 270K Jan 3, 2025 Direct
Candel Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 90K Apr 28, 2023 Direct
Acer Therapeutics Inc. Director Stock Option (right to buy) 20K Mar 14, 2023 Direct

Insider Reports Filed by Jason Amello

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TCRX TScan Therapeutics, Inc. Jan 3, 2025 1 $0 4 Feb 11, 2025 Chief Financial Officer
TCRX TScan Therapeutics, Inc. Feb 1, 2024 1 $0 4 Feb 2, 2024 Chief Financial Officer
TCRX TScan Therapeutics, Inc. Jan 29, 2024 0 $0 3 Feb 2, 2024 Chief Financial Officer
CADL Candel Therapeutics, Inc. Nov 28, 2023 1 -$18.1K 4 Nov 30, 2023 Chief Financial Officer
CADL Candel Therapeutics, Inc. Nov 26, 2023 1 $0 4 Nov 28, 2023 Chief Financial Officer
CADL Candel Therapeutics, Inc. Apr 28, 2023 1 $0 4 May 2, 2023 Chief Financial Officer
ACER Acer Therapeutics Inc. Mar 14, 2023 1 $0 4 Mar 16, 2023 Director
CADL Candel Therapeutics, Inc. Dec 8, 2022 2 $10K 4 Dec 12, 2022 Chief Financial Officer
CADL Candel Therapeutics, Inc. Nov 28, 2022 1 $0 4 Nov 30, 2022 Chief Financial Officer
CADL Candel Therapeutics, Inc. Sep 21, 2022 1 $0 4 Sep 23, 2022 Chief Financial Officer
CADL Candel Therapeutics, Inc. Sep 21, 2022 0 $0 3 Sep 23, 2022 Chief Financial Officer
ACER Acer Therapeutics Inc. Jan 14, 2022 1 $0 4 Jan 19, 2022 Director